SS Innovations International Inc. Common Stock (SSII) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
SS Innovations International Inc. Common Stock stock (SSII) is currently trading at $4.86. SS Innovations International Inc. Common Stock PS ratio (Price-to-Sales) is 23.27. WallStSmart rates SSII as Sell.
- SSII PE ratio analysis and historical PE chart
- SSII PS ratio (Price-to-Sales) history and trend
- SSII intrinsic value — DCF, Graham Number, EPV models
- SSII stock price prediction 2025 2026 2027 2028 2029 2030
- SSII fair value vs current price
- SSII insider transactions and insider buying
- Is SSII undervalued or overvalued?
- SS Innovations International Inc. Common Stock financial analysis — revenue, earnings, cash flow
- SSII Piotroski F-Score and Altman Z-Score
- SSII analyst price target and Smart Rating
SS Innovations International Inc.
📊 No data available
Try selecting a different time range
Smart Analysis
SS Innovations International Inc. Common Stock (SSII) · 8 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in revenue growth. Concerns around return on equity and operating margin. Significant fundamental concerns warrant caution or avoidance.
SS Innovations International Inc. Common Stock (SSII) Key Strengths (1)
Revenue surging 192.50% year-over-year
SS Innovations International Inc. Common Stock (SSII) Areas to Watch (7)
Company is destroying shareholder value
Losing money on operations
Company is losing money with a negative profit margin
Very expensive at 23.3x annual revenue
Very expensive at 26.2x book value
Very low institutional interest at 0.21%
Small-cap company with higher risk but more growth potential
Supporting Valuation Data
SS Innovations International Inc. Common Stock (SSII) Detailed Analysis Report
Overall Assessment
This company scores 20/100 in our Smart Analysis, earning a F grade. Out of 8 metrics analyzed, 1 register as strengths (avg 10.0/10) while 7 fall into concern territory (avg 1.6/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Revenue Growth. Growth metrics are encouraging with Revenue Growth at 192.50%.
The Bear Case
The primary concerns are Return on Equity, Operating Margin, Profit Margin. Some valuation metrics including Price/Sales (23.27), Price/Book (26.16) suggest expensive pricing. Profitability pressure is visible in Return on Equity at -43.40%, Operating Margin at -14.30%, Profit Margin at -32.10%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -43.40% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 192.50% strong but requiring continuation.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
SSII Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
SSII's Price-to-Sales ratio of 23.27x trades at a deep discount to its historical average of 365.99x (7th percentile). The current valuation is 99% below its historical high of 2064.58x set in Jul 2023, and 121% above its historical low of 10.54x in Aug 2024. Over the past 12 months, the PS ratio has compressed from ~88.1x as trailing revenue scaled faster than the stock price.
WallStSmart Analysis Synopsis
Data-driven financial summary for SS Innovations International Inc. Common Stock (SSII) · HEALTHCARE › MEDICAL DEVICES
The Big Picture
SS Innovations International Inc. Common Stock is in a high-growth phase, prioritizing rapid expansion over margins. Revenue reached 36M with 193% growth year-over-year. The company is currently unprofitable, posting a -32.1% profit margin.
Key Findings
Revenue growing at 193% YoY, reaching 36M. This pace significantly outperforms most MEDICAL DEVICES peers.
The company is unprofitable with a -32.1% profit margin. The path to breakeven will be the key catalyst.
Free cash flow is -3M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Growth sustainability: can SS Innovations International Inc. Common Stock maintain 193%+ revenue growth, or will competition slow it down?
Sector dynamics: monitor MEDICAL DEVICES industry trends, competitive moves, and regulatory changes that could impact SS Innovations International Inc. Common Stock.
Bottom Line
SS Innovations International Inc. Common Stock is a high-conviction growth story with revenue accelerating at 193% while profitability is still developing. For growth-oriented investors, the trajectory is compelling. For value investors, the thin -32.1% margins and premium valuation suggest patience until the unit economics mature further.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Data sourced from SEC Form 4 filings
Last updated: 10:00:47 AM
About SS Innovations International Inc. Common Stock(SSII)
NASDAQ
HEALTHCARE
MEDICAL DEVICES
USA
SS Innovations International, Inc., is a commercial-stage surgical robotics company in India and internationally. The company is headquartered in Gurugram, India.